Literature DB >> 35550538

Effects of Probiotic Bacteria on Central Neuronal Activation in Experimental Colitis.

Neriman Şengül1, Fatma Töre2, Sevil Işık3, Belma Aslım4, Gülberk Uçar5, Tülin Fırat6, Samiye Yabanoğlu Çiftçi5, Aysel Kükner7.   

Abstract

BACKGROUND: Brain-gut axis dysregulation is observed in inflammatory bowel disease. However, the effect of altered gut flora on neuro- immunomodulation and its role in the pathogenesis of inflammatory bowel disease are unknown. The aims of this study are to determine (i) whether colitis modifies the expression of c-fos, a marker of general neuronal activation in the brain and (ii) whether this activation could be modulated by probiotic bacteria.
METHODS: In this study, 28 Sprague-Dawley rats were divided into 4 groups: colitis-probiotic group, non-colitis-fed-control group receiv- ing probiotic Lactobacillus delbrueckii subsp. Bulgaricus B3 strain for 7 days, colitis group, and sham group receiving only sodium chlo- ride. Colitis was induced by intracolonic administration of trinitrobenzene sulfonic acid-ethanol. The expression of c-fos was detected by immunohistochemistry in the brain tissue. Cytokines and inflammatory mediators were analyzed in the plasma. Histological scores and oxidative status were analyzed in the colon samples.
RESULTS: The inflammatory response was accompanied by increased levels of cytokines, lipid peroxidation activities, c-fos expression in the medial nucleus of the amygdala, and decreased levels of antioxidant enzymes in the colitis (P < .001). Probiotic treatment reversed those effects. Also, histopathologic scores were significantly lower in the probiotic-treated groups compared to the colitis group (P = .035). In contrast, the expression of c-fos was significantly increased in the paraventricular nucleus of hypothalamus in the probiotic- treated rats (P < .001).
CONCLUSION: Colitis and intestinal inflammation are associated with the activation of neurons in the limbic system creating stress-like effects in the brain. Probiotics diversely modulate limbic response and hypothalamic axis activity in addition to protective effects in inflammation.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35550538      PMCID: PMC9153295          DOI: 10.5152/tjg.2022.201175

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.555


  16 in total

Review 1.  Role of the microbiota in inflammatory bowel diseases.

Authors:  Nabeetha A Nagalingam; Susan V Lynch
Journal:  Inflamm Bowel Dis       Date:  2011-09-20       Impact factor: 5.325

Review 2.  Host-gut microbiota metabolic interactions.

Authors:  Jeremy K Nicholson; Elaine Holmes; James Kinross; Remy Burcelin; Glenn Gibson; Wei Jia; Sven Pettersson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

Review 3.  Psychological stress in IBD: new insights into pathogenic and therapeutic implications.

Authors:  J E Mawdsley; D S Rampton
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

4.  The effect of exopolysaccharide-producing probiotic strains on gut oxidative damage in experimental colitis.

Authors:  Neriman Sengül; Sevil Işık; Belma Aslım; Gülberk Uçar; Ali Eba Demirbağ
Journal:  Dig Dis Sci       Date:  2010-08-04       Impact factor: 3.199

5.  Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial.

Authors:  Mahdi Shadnoush; Rahebeh Shaker Hosseini; Ahad Khalilnezhad; Lida Navai; Hossein Goudarzi; Maryam Vaezjalali
Journal:  Korean J Gastroenterol       Date:  2015-04

Review 6.  Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review.

Authors:  Mahboube Ganji-Arjenaki; Mahmoud Rafieian-Kopaei
Journal:  J Cell Physiol       Date:  2017-05-03       Impact factor: 6.384

7.  Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population.

Authors:  Winfried Häuser; Karl-Heinz Janke; Bodo Klump; Andreas Hinz
Journal:  Inflamm Bowel Dis       Date:  2011-02       Impact factor: 5.325

8.  Vasoactive Intestinal peptide modulates c-Fos activity in the trigeminal nucleus and dura mater mast cells in sympathectomized rats.

Authors:  Erkan Kilinc; Tülin Firat; Fatma Tore; Aysu Kiyan; Aysel Kukner; Nese Tunçel
Journal:  J Neurosci Res       Date:  2014-12-04       Impact factor: 4.164

Review 9.  Probiotics for Gastrointestinal Conditions: A Summary of the Evidence.

Authors:  Thad Wilkins; Jacqueline Sequoia
Journal:  Am Fam Physician       Date:  2017-08-01       Impact factor: 3.292

Review 10.  The role of microbiome in central nervous system disorders.

Authors:  Yan Wang; Lloyd H Kasper
Journal:  Brain Behav Immun       Date:  2013-12-25       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.